Apeiron Investment Group Ltd. — SEC Form 4 filings
SEC reporting owner CIK 1845711. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-03-06 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 8 filings — 23,741,653 shares, $48,333,833 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 272,070 shares, $82,527 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: purchase of 10,835,718 shares @ $2.10 ($22,755,008) in ATAI Life Sciences N.V., filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ATAI Life Sciences N.V. (ATAI) | 10% owner | 5 | 3 legs · 21,311,517 sh · $44,275,008 | — | 4 |
| Enhanced Group Inc. (ENHA) | Director, 10% owner | 7 | 10 legs · 2,430,136 sh · $4,058,825 | — | 7 |
| BIONOMICS LTD/ADR (BNOX) | 10% owner | 1 | — | 3 legs · 272,070 sh · $82,527 | — |
| AtaiBeckley Inc. (ATAI) | 10% owner | 2 | — | — | 16 |
| Alto Neuroscience, Inc. (ANRO) | — | 1 | — | — | 6 |
Form 4 filings — Apeiron Investment Group Ltd.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | AtaiBeckley Inc. (ATAI) jointly with Angermayer Christian | Disposition to issuer (D): 559,232 · Disposition to issuer (D): 53,398,214 · Disposition to issuer (D): 1,799,302 · Disposition to issuer (D): 624,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 17,930 (derivative) · +4 more | EDGAR |
| 2026-09-09 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Purchase (P): 21,034 @ $1.61 · Purchase (P): 59,337 @ $1.57 · Purchase (P): 99,342 @ $1.60 | EDGAR |
| 2026-09-04 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Purchase (P): 107,693 @ $1.58 · Purchase (P): 25,414 @ $1.58 | EDGAR |
| 2026-08-20 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Grant/award (A): 2,120,823 · Purchase (P): 93,000 @ $1.70 · Purchase (P): 1,619,316 @ $1.66 · Purchase (P): 55,000 @ $1.64 · Grant/award (A): 2,120,823 (derivative) | EDGAR |
| 2026-08-18 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Purchase (P): 200,000 @ $1.65 | EDGAR |
| 2026-08-17 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Purchase (P): 150,000 @ $1.97 | EDGAR |
| 2026-07-24 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Grant/award (A): 3,020,565 · Grant/award (A): 3,020,565 (derivative) | EDGAR |
| 2026-05-11 | 4 | Enhanced Group Inc. (ENHA) jointly with Enhanced Holdings LP, Angermayer Christian | Grant/award (A): 29,692,247 · Grant/award (A): 258,837,933 · Grant/award (A): 212,499 (derivative) | EDGAR |
| 2026-04-10 | 4 | AtaiBeckley Inc. (ATAI) jointly with Angermayer Christian | Option exercise (M): 46,070 @ $1.88 · Option exercise (M): 410,162 @ $1.64 · Option exercise (M): 103,000 @ $1.34 · Option exercise (M): 46,070 (derivative) @ $0 · Option exercise (M): 410,162 (derivative) @ $0 · Option exercise (M): 103,000 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | ATAI Life Sciences N.V. (ATAI) jointly with Angermayer Christian | Conversion (C): 2,367,200 · Conversion (C): 147,950 (derivative) | EDGAR |
| 2025-08-18 | 4 | ATAI Life Sciences N.V. (ATAI) jointly with Angermayer Christian | Purchase (P): 8,675,799 @ $2.19 | EDGAR |
| 2025-03-24 | 4 | ATAI Life Sciences N.V. (ATAI) jointly with Angermayer Christian | Purchase (P): 1,800,000 @ $1.40 | EDGAR |
| 2025-02-19 | 4 | ATAI Life Sciences N.V. (ATAI) jointly with Angermayer Christian | Purchase (P): 10,835,718 @ $2.10 | EDGAR |
| 2024-10-07 | 4 | BIONOMICS LTD/ADR (BNOX) jointly with Apeiron Presight Capital Fund II, L.P., Angermayer Christian | Sale (S): 90,806 @ $0.33 · Sale (S): 180,707 @ $0.29 · Sale (S): 557 @ $0.28 | EDGAR |
| 2024-04-17 | 4 | ATAI Life Sciences N.V. (ATAI) jointly with Angermayer Christian | Other (J): 147,950 (derivative) · Other (J): 147,950 (derivative) | EDGAR |
| 2024-03-06 | 4 | Alto Neuroscience, Inc. (ANRO) jointly with Apeiron Presight Capital Fund II, L.P., Angermayer Christian | Conversion (C): 251,881 · Conversion (C): 674,658 · Conversion (C): 444,561 (derivative) · Conversion (C): 406,072 (derivative) · Conversion (C): 1,063,918 (derivative) · Conversion (C): 416,665 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1845711 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →